J Am Dent Assoc. 2019 Apr;150(4):259-268.e1. doi: 10.1016/j.adaj.2018.12.030.
Dentists contribute to the prevailing opioid epidemic in the United States. Concerning the population enrolled in Medicaid, little is known about dentists' opioid prescribing.
The authors performed a retrospective cohort study of beneficiaries of Medicaid in Washington state with dental claims in 2014 and 2015. The primary outcome was the proportion of dental visits associated with an opioid prescription. The authors categorized visits as invasive or noninvasive by using procedure codes and each beneficiary as being at low or high risk by using his or her prescription history from the prescription drug monitoring program.
A total of 126,660 (10.3%) of all dental visits, most of which were invasive (66.9%), among the population enrolled in Medicaid in Washington state was associated with opioid prescriptions. However, noninvasive dental visits and visits for beneficiaries who had prior high-risk prescription use were associated with significantly higher mean days' supply and mean quantity of opioids prescribed. Results from the multivariate logistic regression showed that the probability of having an opioid-associated visit increased by 35.6 percentage points when the procedures were invasive and by 11.1 percentage points when the beneficiary had prior high-risk prescription use.
This baseline of opioid prescribing patterns after dental visits among the population enrolled in Medicaid in Washington state in 2014 and 2015 can inform future studies in which the investigators examine the effect of policies on opioid prescribing patterns and reasons for the variability in the dosage and duration of opioid prescriptions associated with noninvasive visits.
Dentists must exercise caution when prescribing opioids during invasive visits and to patients with prior high-risk prescription use.
牙医在美国流行的阿片类药物泛滥中起到了推波助澜的作用。关于参加医疗补助计划(Medicaid)的人群,牙医开阿片类药物处方的情况知之甚少。
作者对华盛顿州参加医疗补助计划且在 2014 年和 2015 年有牙科报销的受益人群进行了回顾性队列研究。主要结果是与阿片类药物处方相关的牙科就诊比例。作者通过程序代码将就诊分为侵入性和非侵入性,根据处方药物监测计划中的每位受益人的用药史,将每个受益人群分为低风险或高风险。
在华盛顿州参加医疗补助计划的人群中,共有 126660 次(占 10.3%)牙科就诊与阿片类药物处方相关,其中大多数就诊为侵入性(66.9%)。然而,非侵入性牙科就诊和之前有高风险用药史的受益人的就诊与开出的阿片类药物的平均日供应量和平均数量显著相关。多变量逻辑回归结果表明,当程序为侵入性时,就诊与阿片类药物相关的概率增加 35.6 个百分点,当受益人与之前有高风险用药史时,该概率增加 11.1 个百分点。
这项 2014 年和 2015 年华盛顿州参加医疗补助计划的人群在牙科就诊后开出阿片类药物的模式基准可以为未来的研究提供信息,未来的研究将考察政策对阿片类药物处方模式的影响,以及与非侵入性就诊相关的阿片类药物剂量和持续时间差异的原因。
牙医在进行侵入性治疗和为有之前高风险用药史的患者开具阿片类药物时必须谨慎。